SCHEMBL4666860

SCHEMBL4666860

Cc1cncc(C)c1-n1nc(-c2cccc(OC(C)C)c2)cc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
WDR5 P61964 1/20 0.43
MAP4K4 O95819 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42
GABRA5 P31644 1/20 0.42
GABRA3 P34903 1/20 0.42
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
MAPT P10636 4/20 0.38
BACE1 P56817 1/20 0.38
KLK3 P07288 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4666815 0.80 ALDH1A1 (0.42) ALDH1A1NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL4666570 0.77 SMN1; SMN2 (0.48) ALDH1A1NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL14600673 0.75 DHODH (0.47) ALDH1A1RAB9AL3MBTL1GABRA1GABRG2
Hydrochloric Acid SCHEMBL4666221 0.73 DHODH (0.57) KEAP1NFE2L2MAPTTP53
SCHEMBL4668988 0.73 DHODH (0.49) WDR5KEAP1NFE2L2MAPTTEK
SCHEMBL14600674 0.73 DHODH (0.44) KEAP1NFE2L2MAPTTEKRXRA
SCHEMBL14600681 0.70 DHODH (0.44) ALDH1A1L3MBTL1KEAP1NFE2L2MAPT
SCHEMBL20557906 0.68 RXRA (0.57) ALDH1A1WDR5MAP4K4GABRA1GABRG2
SCHEMBL30469319 0.68 RXRA (0.57) ALDH1A1WDR5MAP4K4GABRA1GABRG2
SCHEMBL23809593 0.67 MAP4K4 (0.62) WDR5MAP4K4GABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed